Recerca > Nutrició, Metabolisme i Estrès Cel·lular

Fisiopatologia metabòlica

Nombre de publicacions
422
Cercador de publicacions
  • Fernàndez-Bernal, A; Goya-Iglesias, N; Company-Marin, I; Mota-Martorell, N; Pekna, M; Pekny, M; Sol, J; Obis, E; Pamplona, R; Pajares, MA; Pérez-Sala, D; Jové, M

    GFAP mutants cause imbalance of selective lipid classes in a cellular model of Alexander disease

    iScience 29 -. .

    [doi:10.1016/j.isci.2026.117903]

  • Brault-Boixader, N; Roca-Ventura, A; Delgado-Gallén, S; Buloz-Osorio, E; Boccuni, L; Laredo, C; Munoz-Moreno, E; Bargallo, N; Bartrés-Faz, D; Pascual-Leone, A; Tormos-Munoz, JM; Perellón-Alfonso, R; Abellaneda-Pérez, K

    Non-invasive prehabilitation before neurosurgery modifies the topography of the language production network without compromising function

    NEUROIMAGE 339 122185-122185. .

    [doi:10.1016/j.neuroimage.2026.122185]

  • Alvarez BE; Bravo MO; Barberà EA; Machado L; Ensenyat A; Garcia PG; Sol J

    Changes in Physical Activity and Psychological Status in Patients with COPD Between Pre- and Post-COVID-19 Assessments: A Pilot Observational Longitudinal Cohort Study.

    Healthcare 14 -. .

    [doi:10.3390/healthcare14193142]

  • Fernández-Beltrán, LC; Garcia-Toledo, I; García, KJ; Jiménez-Coca, I; Jimésnez-Rodríguez, J; Fernández-Bernal, A; Godoy-Corchuelo, JM; Portero-Otin, M; Corrochano, S

    Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS

    Neurotherapeutics 23 -. .

    [doi:10.1016/j.neurot.2026.e01062]

  • Llubes-Arrià, L; Boonekamp, G; Brummel, A; Sol-Culleré, J; Mateos, JT; Salanterä, S

    Spanish adaptation and validation of the Capability Cards for use in community primary health care

    Primary Health Care Research & Development 27 -. .

    [doi:10.1017/S1463423626101583]

  • Ceron-Codorniu, M; Fernàndez-Bernal, A; Pamplona, R; Portero-Otín, M

    TDP-43 loss-of-function triggers mitochondrial dysfunction and metabolic imbalance

    Neural Regeneration Research 21 3512-3514. .

    [doi:10.4103/NRR.NRR-D-25-00167]

  • Serrano, JCE; Castro-Boqué, E; García-Carrasco, A; Morán-Valero, MI; Municio, MD; Bermúdez-López, M; Valdivielso, JM; Espinel, AE; Portero-Otín, M

    Effects of aged black garlic (ABG10+®) on lipoprotein subclass composition in Grade I hypertension: a randomized, triple-blind controlled trial with sex-stratified sequential allocation

    Frontiers in Nutrition 13 1869617-1869617. .

    [doi:10.3389/fnut.2026.1869617]

  • Miralles MP; Gimenez-Fernandez I; Beltran M; Sansa A; Martínez-España L; Calderó J; Portero-Otín M; Soler RM; Garcera A

    Antisense oligonucleotides treatment uncovers differences in the modulation of dysregulated intracellular pathways in Spinal Muscular Atrophy motoneurons.

    Cell Death & Disease 17 -. .

    [doi:10.1038/s41419-026-09105-1]

  • Torres, P; Sánchez, AG; Sancho-Saldaña, A; Quibus, L; Murillo, ES; Ruiz-Fernández, E; Peralta, S; Solana, MJ; Brieva, L; González-Mingot, C

    18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis

    MOLECULAR NEUROBIOLOGY 63 -. .

    [doi:10.1007/s12035-026-05915-8]

  • Izarra, A; Bermúdez-López, M; Valdivielso, JM; Soler, MJ; Pamplona, R; Torres, G; Mauricio, D; Castro-Boqué, E; Fernández, E; Hernández, M; Simó, R; Hernández, C; Lecube, A

    Baseline and Follow-Up Association between Adiposity and Renal Function: Data from the ILERVAS Cohort

    Obesity Facts 1-11. .

    [doi:10.1159/000552362]

  • Torres-Querol, C; Pamplona, R; Arqué, G; Purroy, F

    Remote ischemic perconditioning and postconditioning reduced cerebral ischemic injury modulating inflammatory responses and metabolic pathways

    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 46 2461-2478. .

    [doi:10.1177/0271678X261458135]

  • Izarra, A; Bermúdez-López, M; Valdivielso, JM; Pamplona, R; Torres, G; Mauricio, D; Castro-Boqué, E; Fernández, E; Simó, R; Hernández, C; Lecube, A

    Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

    DIABETES OBESITY & METABOLISM 28 3777-3787. .

    [doi:10.1111/dom.70560]